These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 29845530)

  • 21. Extended substrate specificity and first potent irreversible inhibitor/activity-based probe design for Zika virus NS2B-NS3 protease.
    Rut W; Zhang L; Kasperkiewicz P; Poreba M; Hilgenfeld R; Drąg M
    Antiviral Res; 2017 Mar; 139():88-94. PubMed ID: 28034744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex.
    Kim YM; Gayen S; Kang C; Joy J; Huang Q; Chen AS; Wee JL; Ang MJ; Lim HA; Hung AW; Li R; Noble CG; Lee le T; Yip A; Wang QY; Chia CS; Hill J; Shi PY; Keller TH
    J Biol Chem; 2013 May; 288(18):12891-900. PubMed ID: 23511634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses.
    Rut W; Groborz K; Zhang L; Modrzycka S; Poreba M; Hilgenfeld R; Drag M
    Antiviral Res; 2020 Mar; 175():104731. PubMed ID: 32014497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of cellular proteome changes in response to ZIKV NS2B-NS3 protease expression.
    Tangsongcharoen C; Roytrakul S; Smith DR
    Biochim Biophys Acta Proteins Proteom; 2019 Feb; 1867(2):89-97. PubMed ID: 30391636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel small molecule inhibitors against NS2B/NS3 serine protease from Zika virus.
    Lee H; Ren J; Nocadello S; Rice AJ; Ojeda I; Light S; Minasov G; Vargas J; Nagarathnam D; Anderson WF; Johnson ME
    Antiviral Res; 2017 Mar; 139():49-58. PubMed ID: 28034741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo.
    Yuan S; Chan JF; den-Haan H; Chik KK; Zhang AJ; Chan CC; Poon VK; Yip CC; Mak WW; Zhu Z; Zou Z; Tee KM; Cai JP; Chan KH; de la Peña J; Pérez-Sánchez H; Cerón-Carrasco JP; Yuen KY
    Antiviral Res; 2017 Sep; 145():33-43. PubMed ID: 28712942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of NS2B-NS3 protease inhibitor that impairs Zika virus replication.
    Lin WW; Huang YJ; Wang YT; Lin YS; Mazibuko N; Chen CS; Cheng TL; Chang CS; Leu YL; Chen CY; Chuang CH
    Virus Res; 2023 May; 329():199092. PubMed ID: 36965673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding mode of the activity-modulating C-terminal segment of NS2B to NS3 in the dengue virus NS2B-NS3 protease.
    de la Cruz L; Chen WN; Graham B; Otting G
    FEBS J; 2014 Mar; 281(6):1517-33. PubMed ID: 24472363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The New High Resolution Crystal Structure of NS2B-NS3 Protease of Zika Virus.
    Badshah SL; Naeem A; Mabkhot Y
    Viruses; 2017 Jan; 9(1):. PubMed ID: 28075376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homology modeling and molecular dynamics simulations of Dengue virus NS2B/NS3 protease: insight into molecular interaction.
    Wichapong K; Pianwanit S; Sippl W; Kokpol S
    J Mol Recognit; 2010; 23(3):283-300. PubMed ID: 19693793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual function of Zika virus NS2B-NS3 protease.
    Shiryaev SA; Cieplak P; Cheltsov A; Liddington RC; Terskikh AV
    PLoS Pathog; 2023 Nov; 19(11):e1011795. PubMed ID: 38011215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of flavonoids against NS2B-NS3 protease of ZIKA virus and their structure activity relationship.
    Lim HJ; Nguyen TT; Kim NM; Park JS; Jang TS; Kim D
    Biotechnol Lett; 2017 Mar; 39(3):415-421. PubMed ID: 27885509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NS2B-NS3 protease inhibitors as promising compounds in the development of antivirals against Zika virus: A systematic review.
    Nunes DAF; Santos FRDS; da Fonseca STD; de Lima WG; Nizer WSDC; Ferreira JMS; de Magalhães JC
    J Med Virol; 2022 Feb; 94(2):442-453. PubMed ID: 34636434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.
    Li Z; Brecher M; Deng YQ; Zhang J; Sakamuru S; Liu B; Huang R; Koetzner CA; Allen CA; Jones SA; Chen H; Zhang NN; Tian M; Gao F; Lin Q; Banavali N; Zhou J; Boles N; Xia M; Kramer LD; Qin CF; Li H
    Cell Res; 2017 Aug; 27(8):1046-1064. PubMed ID: 28685770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.
    Yao Y; Huo T; Lin YL; Nie S; Wu F; Hua Y; Wu J; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y
    J Am Chem Soc; 2019 May; 141(17):6832-6836. PubMed ID: 31017399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition.
    Coronado MA; Eberle RJ; Bleffert N; Feuerstein S; Olivier DS; de Moraes FR; Willbold D; Arni RK
    Antiviral Res; 2018 Dec; 160():118-125. PubMed ID: 30393012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allosteric Inhibitors of Zika Virus NS2B-NS3 Protease Targeting Protease in "Super-Open" Conformation.
    Meewan I; Shiryaev SA; Kattoula J; Huang CT; Lin V; Chuang CH; Terskikh AV; Abagyan R
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
    Majerová T; Novotný P; Krýsová E; Konvalinka J
    Biochimie; 2019 Nov; 166():132-141. PubMed ID: 31077760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zika Virus NS2A-Mediated Virion Assembly.
    Zhang X; Xie X; Xia H; Zou J; Huang L; Popov VL; Chen X; Shi PY
    mBio; 2019 Oct; 10(5):. PubMed ID: 31662457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cysteine Disulfide Traps Reveal Distinct Conformational Ensembles in Dengue Virus NS2B-NS3 Protease.
    Hill ME; Yildiz M; Hardy JA
    Biochemistry; 2019 Feb; 58(6):776-787. PubMed ID: 30472839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.